Dr. Suzanne R. Fanning
Claim this profilePrisma Health Cancer Institute - Eastside
Area of expertise
Lymphoma
Suzanne R. Fanning has run 4 trials for Lymphoma. Some of their research focus areas include:
Acute Myelogenous Leukemia
Suzanne R. Fanning has run 4 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Prisma Health Cancer Institute - Eastside
Prisma Health Cancer Institute - Spartanburg
Clinical Trials Suzanne R. Fanning is currently running
Venetoclax + HMA
for Acute Myeloid Leukemia
This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3 mutations. Azacitidine is a drug that is absorbed into DNA and leads to the activation of cancer suppressor genes, which are genes that help control cell growth. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Gilteritinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. This study may help doctors find out if these different approaches are better than the usual approaches. To decide if they are better, the study doctors are looking to see if the study drugs lead to a higher percentage of patients achieving a deeper remission compared to the usual approach.
Recruiting
1 award
Phase 2
7 criteria
Iberdomide
for Multiple Myeloma
This phase II trial compares iberdomide maintenance therapy to disease monitoring for improving survival in patients who have received idecabtagene vicleucel (a type of chimeric antigen receptor T-cell \[CAR-T\] therapy) for multiple myeloma. The usual approach after treatment with idecabtagene vicleucel is to monitor the multiple myeloma without giving myeloma medications. There is currently no medication approved specifically for use after idecabtagene vicleucel treatment. Upon administration, iberdomide modifies the immune system and activates immune cells called T-cells, which could enhance the effectiveness of idecabtagene vicleucel. Iberdomide may keep multiple myeloma under control for longer than the usual approach (disease monitoring) after idecabtagene vicleucel, and may help multiple myeloma patients live longer.
Recruiting
1 award
Phase 2
10 criteria
More about Suzanne R. Fanning
Clinical Trial Related
1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 11 Active Clinical Trials
Treatments Suzanne R. Fanning has experience with
- Venetoclax
- Cytarabine
- Azacitidine
- Daunorubicin Hydrochloride
- Dexamethasone
- Cyclophosphamide
Breakdown of trials Suzanne R. Fanning has run
Lymphoma
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Suzanne R. Fanning specialize in?
Suzanne R. Fanning focuses on Lymphoma and Acute Myelogenous Leukemia. In particular, much of their work with Lymphoma has involved 13q positive patients, or patients who are 13q negative.
Is Suzanne R. Fanning currently recruiting for clinical trials?
Yes, Suzanne R. Fanning is currently recruiting for 11 clinical trials in Greenville South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Suzanne R. Fanning has studied deeply?
Yes, Suzanne R. Fanning has studied treatments such as Venetoclax, Cytarabine, Azacitidine.
What is the best way to schedule an appointment with Suzanne R. Fanning?
Apply for one of the trials that Suzanne R. Fanning is conducting.
What is the office address of Suzanne R. Fanning?
The office of Suzanne R. Fanning is located at: Prisma Health Cancer Institute - Eastside, Greenville, South Carolina 29615 United States. This is the address for their practice at the Prisma Health Cancer Institute - Eastside.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.